Prognostic staging system for hepatocellular carcinoma (CLIP score): Its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score)

Journal of Gastroenterology

Volumn 38, Issue 3, 2003, Pages 207-215

  Kudo, Masatoshi ^a   Chung, Hobyung ^a   Osaki, Yukio ^b  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA RED CROSS HOSPITAL   (Japan)

Author keywords

BCLC classification; CLIP score; Hepatocellular carcinoma; Japan integrated staging score (JIS score); Prognostic staging system

Indexed keywords

CANCER CLASSIFICATION; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; DISEASE SEVERITY; EARLY CANCER; HUMAN; INTERMETHOD COMPARISON; JAPAN; LIFE EXPECTANCY; LIVER CELL CARCINOMA; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; POPULATION DISTRIBUTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCORING SYSTEM; STRATIFICATION; TUMOR VOLUME;

CARCINOMA, HEPATOCELLULAR; HUMANS; JAPAN; LIVER NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 0038748320     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350300038     Document Type: Review

References (43)

1. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918-28.
2. Izumi R, Shimizu K, Ii T, Yagi M, Matsui O, Nonomura A, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology 1994;106:720-7.
3. Staudacher C, Chiappa A, Biella F, Audisio RA, Bertani E, Zbar AP, et al. Validation of the modified TNM-Izumi classification for hepatocellular carcinoma. Tumori 2000;86:8-11.
4. Marsh JW, Dvorchik I, Bonham CA, Iwatsuki S. Is the pathologic TNM staging system for patients with hepatoma predictive of outcome? Cancer 2000;88:538-43.
5. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node metastasis classification does not have prognostic power. Hepatology 1998;27:1572-7.
6. Lui WY, Chiu JH, Loong CC, Chau GY, King KL, Hsia CY, et al. Evaluation of a simplified staging system for prognosis of hepatocellular carcinoma. J Formos Med Assoc 1999;4:248-53.
7. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 3rd ed. Tokyo: Kanehara; 1992. p. 15.
8. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer (in Japanese). 4th ed. Tokyo: Kanehara; 2000. p. 19.
9. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology 2000;32:1224-9.
10. Sasaki Y, Imaoka K, Nakano H, Ishikawa O, Ohigashi H, Yasuda T, et al. Indications for hepatectomy for hepatocellular carcinoma - what stage of the disease is the best indication for surgery? J Hepatobiliary Pancreat Surg 1998;5:14-7.
11. The Cancer of the Liver Italian Program (CLIP) Investigators. A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients. Hepatology 1998;28:751-5.
12. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al. AJCC cancer staging manual. Philadelphia: Lippincott-Raven, 1997.
13. International Union Against Cancer (UICC). Sobin LH, Wittekind Ch, editors. TNM classification of malignant tumours. 5th ed. New York: Wiley-Liss, 1997.
14. Sobin LH, Fleming ID, editors. TNM classification of malignant tumours. 5th ed. New York: Wiley and Sons, 1997.
15. Calvet X, Bruix J, Bru C, Gines P, Vilana R, Sole M, et al. Natural history of hepatocellular carcinoma in Spain. Five years' experience in 249 cases. J Hepatol 1990;10:311-7.
16. Chen MF, Hwang TL, Jeng LB, Jan YY, Chou FF, Wang SC. Hepatic resection in 120 patients with hepatocellular carcinoma. Arch Surg 1989;124:1025-8.
17. Yamanaka N, Okamoto E, Toyosaka A, Mitunobu M, Fujihara S, Kato T, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas. Cancer 1990;65:1104-10.
18. Arii S, Okamoto E, Imamura M. Registries in Japan: current status of hepatocellular carcinoma in Japan. Liver Cancer Study Group of Japan. Semin Surg Oncol 1996;12:204-11.
19. Yamashita Y, Takahashi M, Koga Y, Saito R, Nanakawa S, Hatanaka Y, et al. Prognostic factor in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion. Cancer 1991;67:385-91.
20. Taniguchi K, Nakata K, Kato Y, Sato Y, Hamasaki K, Tsuruta S, et al. Treatment of hepatocellular carcinoma with transcatheter arterial embolization. Cancer 1994;73:1341-5.
21. Attali P, Prod'Homme S, Pelletier G, Papoz L, Ink O, Buffet C, et al. Prognostic factor in patients with hepatocellular carcinoma. Cancer 1987;59:2108-11.
22. Akashi Y, Koreeda C, Enomoto S, Uchiyama S, Mizuno T, Shiozaki Y, et al. Prognosis of unresectable hepatocellular carcinoma: an evaluation based on multivariate analysis of 90 cases. Hepatology 1991;14:262-8.
23. Shijo H, Okazaki M, Higashihara H, Koganemaru F, Okumura M. Hepatocellular carcinoma: a multivariate analysis of prognostic features in patients treated with hepatic arterial embolization. Am J Gastroenterol 1992;87:1154-9.
24. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Cancer 1989;64:1700-7.
25. Nagasue N, Yukaya H, Hamada T, Hirose S, Kanashima R, Inokuchi K. The natural history of hepatocellular carcinoma. Cancer 1984;54:1461-5.
26. Primack A, Vogel Ch, Kyalwazi S, Ziegler JL, Simon R, Anthony PP. A staging system for hepatocellular carcinoma: prognostic factors in Ugandan patients. Cancer 1975;35:1357-64.
27. Chlebowski R, Tong M, Weissman J, Block JB, Ramming KP, Weiner JM, et al. Hepatocellular carcinoma. Diagnostic and prognostic features in north American patients. Cancer 1984;53:2701-6.
28. Sheu JC, Sung JL, Chen DS, Yang PM, Lai MY, Lee CS, et al. Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications. Gastroenterology 1985;89:259-66.
29. Ebara M, Ohto M, Shinagawa T, Sugiura N, Kimura K, Matsutani S, et al. Natural history of hepatocellular carcinoma smaller than 3 cm complicating cirrhosis. A study in 22 patients. Gastroenterology 1986;90:289-98.
30. Attali P, Prod'Homme, Pelletier G, Papoz L, Ink O, Buffet C, et al. Prognostic factors in patients with hepatocellular carcinoma. Attempts for selection of patients with prolonged survival in hepatocellular carcinoma. Cancer 1987;45:2108-11.
31. Falkson G, Cnaan A, Schutt AJ, Ryan LM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988;48:7314-8.
32. Nerenstone SR, Ihde DC, Friedman MA. Clinical trials in primary hepatocellular carcinoma: current status and future directions. Cancer Treat Rev 1998;15:1-31.
33. Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R, et al. Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. Hepatology 1990;12:753-60.
34. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-7.
35. Pugh RNH Murray-Lyon IM, Dawson JL. Transection of the oesophagus for bleeding oesophageal varices. Br J Sur 1973; 60:646-69.
36. Llove JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19:329-37.
37. The Cancer of the Liver Italian Program (CLIP) Investigators. Prospective validation of the CLIP score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma. Hepatology 2000;31:840-5.
38. The Cancer of the Liver Italian Program. Tamoxifen in treatment of hepatocellular carcinoma: a randomized controlled trial. Lancet 1998;352:17-20.
39. Farinati F, Rinaldi M, Gianni S, Nccarato R. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer 2000;89:2266-73.
40. Levy I, Sherman M, The Liver Cancer Study Group of the University of Toronto. Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto. Gut 2002;150:881-5.
41. Ueno S, Tanabe G, Sako K, Hiwaki T, Hokotate H, Fukukura Y, et al. Discrimination value of the new Western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Hepatology 2001;34:529-34.
42. Llovet JM, Bruix J, BCLC group. Prospective validation of the Cancer of the Liver Italian Program (CLIP) score: a new prognostic system for patients with cirrhosis and hepatocellular carcinoma: correspondence. Hepatology 2000;32:679-80.
43. Orlandi F, Christensen E. A consensus conference on prognostic studies in hepatology. J Hepatol 1999;30:171-2.